SLC6A4STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: a case control study
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The aim of this study was to determine if variable number of tandem repeats (VNTR) in the second intron (STin2) of the serotonin transporter (SLC6A4) gene was associated with tobacco use disorder, successful smoking cessation, or smoking characteristics. In this case-control study, patients with current tobacco use disorder, diagnosed according to DSM IV criteria (n = 185), and never-smokers, diagnosed according to CDC criteria (n = 175), were recruited and received 52 weeks of combined pharmacotherapy and cognitive therapy. Successful smoking cessation was defined as exhaled carbon monoxide < 6 ppm. SLC6A4 gene STin2 VNTR polymorphism was assessed using a Multiplex-PCR-based method. At baseline, participants were evaluated using the Fagerström Test for Nicotine Dependence (FTND) and the ASSIST scale. RESULTS: The STin2.12 allele (OR = 2.45; 95% CI = 1.44-4.15, p < 0.001) was associated with an increased risk for tobacco use disorder, while the STin2.10/10 genotype (OR = 0.42; 95% CI 0.25-0.71, p < 0.001) decreased risk. There were no significant associations between tobacco use disorder and the STin2.10 or STin2.9 alleles or the other genotypes (STin2.12/12, 12/10, 12/9, 10/9 or 9/9). There were no significant associations between the STin2 genotypes and alleles and successful smoking cessation, smoking characteristics and increased alcohol or sedative use risk. CONCLUSIONS: Our results suggest that the STin2.10/10 genotype and STin2.12 allele are associated with tobacco use disorder or nicotine dependence, but not with treatment response or severity of dependence. It is hypothesized that the ST2in.12 allele by modulating the metabolism of serotonin may participate in the pathophysiology of tobacco use disorder or nicotine dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nicotine dependence may therefore be regarded as an operational conditioned response aiming to compensate the depleted serotonergic metabolism in specific brain areas.”
From N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study (2015) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders(DSM)
(2008) · Encyclopedia of Counseling · doi:10.4135/9781412963978.n182 · Cited by 10,830
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120 · cited 1×
“The same gene may in part determine vulnerability for depression when exposed to multiple life stressors [10].”
BackgroundLopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630 · cited 1×
“Background Tobacco use disorder is a leading cause of mortality and disease burden [1,2].”
BackgroundGroup, W. A. W. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00185.x · Cited by 1,982
Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire
Fagerstrom, K. O., & Schneider, N. G. (1989) · Journal of Behavioral Medicine · doi:10.1007/bf00846549 · Cited by 1,598 · cited 4×
“The Fagerström test for Nicotine Dependence (FTND) [42], translated and validated for use in Portuguese [43], was administered to all patients with tobacco use disorder.”
MethodInfluentialEstimates of global mortality attributable to smoking in 2000
Ezzati, M., & Lopez, A. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14338-3 · Cited by 1,247
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140 · cited 3×
“In addition, the effects of nicotine use on serotonin, and smoking- and STin2related changes in the IO&NS-serotonin nexus may activate (neuro)degenerative pathways related to dysfunctions in the hypothalamic-pituitary-adrenal (HPA) axis, microglial activation, mitochondrial dysfunctions, decreased levels of antioxidan…”
BackgroundSelf-citationGenome-wide meta-analyses identify multiple loci associated with smoking behavior
The Tobacco and Genetics Consortium (2010) · Nature Genetics · doi:10.1038/ng.571 · Cited by 1,098
Quitting Smoking Among Adults — United States, 2001–2010
Tanoue, L. T. (2012) · Yearbook of Medicine · doi:10.1016/s0084-3873(12)00225-8 · Cited by 737
Research works printed but not linked: 1
- Nunes SOV, Vargas HO, Castro MR, Machado RCB, Carmo DR: Abordagem intensiva. Abordagem, Prevenção e Tratamento do Tabagismo. Edited by: Nunes SOV, Castro MRP. 2011, Londrina: Eduel, 97-216.
Cited by
N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study
Prado, E., Maes, M., Piccoli, L. G., Baracat, M., Barbosa, D. S., Franco, O., Dodd, S., Berk, M., & Vargas Nunes, S. O. (2015) · Redox Report · doi:10.1179/1351000215y.0000000004 · Cited by 69
Self-citationIurescia, S., Seripa, D., & Rinaldi, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0304-6 · Cited by 73
“association between STin2 polymorphism and tobacco use disorder (TUD) or nicotine dependence susceptibility [36, 43, 54].”
BackgroundBinelli, C., Muñiz, A., Sanches, S., Ortiz, A. E., Navinés, R., Egmond, E., Udina, M., Batalla, A., López‐Solà, C., Crippa, J. A., et al. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2014.09.418 · Cited by 51
“Moreover, data from patients with risk-prone related problems suggests that the 12 repeat alleles are associated to worse treatment outcome in alcohol-dependent patients [48], to an increased risk for tobacco use disorder [49], and that may influence the expression of the brain serotonin transporter in suicide attempt…”
BackgroundSmoking-related general and cause-specific mortality in Estonia
Kõks, G., Fischer, K., & Kõks, S. (2017) · BMC Public Health · doi:10.1186/s12889-017-4590-3 · Cited by 34
“One recent study found an association between the polymorphic variable number tandem repeat (VNTR) in the SLC6A4 gene and increased risk for tobacco use disorder [35].”
BackgroundNunes, S. O. V., de Castro, M. R. P., Moreira, E. G., Guembarovski, R. L., Barbosa, D. S., Vargas, H. O., de Melo, L. G. P., Bortolasci, C. C., Watanabe, M. A. E., Dodd, S., et al. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.11.002 · Cited by 17
“12 allele could play a role in activated IO&NS pathways in mood disorders and TUD as well [8].”
BackgroundSelf-citation
Metadata
- Authors
- Pizzo de Castro, M. R., Maes, M., Guembarovski, R. L., Ariza, C. B., Reiche, E. M. V., Vargas, H. O., Vargas, M. M., de Melo, L. G. P., Dodd, S., Berk, M., Watanabe, M. A. E., & Nunes, S. O. V.
- Affiliations
- Universidade Estadual de Londrina (BR)
- Barwon Health (AU)
- Corresponding author
- Maes, Michael
- ORCID
- Venue
- BMC Genetics
- Published
- 2014-06-27
- Volume
- 15
- Issue
- 1
- Pages
- 78-78
- ISSN
- 1471-2156 (ISSN-L)
- PMC
- PMC4114164
- OpenAlex
- W2024635279
- Cited by
- 13
- References
- 57
- Citations by year
- 2023: 2 · 2022: 1 · 2020: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 3
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMC Genetics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Deakin Research Online (Deakin University) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Araucária
- Universidade Estadual de Londrina
- National Health and Medical Research Council (1059660)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- serotonin transporter, tobacco use disorder, nicotine dependence, smoking cessation, genetic susceptibility
- MeSH terms
- Adult, Alleles, Female, Genotype, Humans, Male, Middle Aged, Polymorphism, Genetic, Smoking, Tobacco Use Disorder, Logistic Models, Case-Control Studies, Smoking Cessation, Minisatellite Repeats, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SLC6A4STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: a case control study. https://app.cochat.ai/papers/10.1186/1471-2156-15-78
- The paper
- Pizzo de Castro, M. R., Maes, M., Guembarovski, R. L., Ariza, C. B., Reiche, E. M. V., Vargas, H. O., Vargas, M. M., de Melo, L. G. P., Dodd, S., Berk, M., Watanabe, M. A. E., & Nunes, S. O. V. (2014). SLC6A4STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: a case control study. BMC Genetics. https://doi.org/10.1186/1471-2156-15-78
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.